Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (12)

2024

  1. Effectiveness of Treatment Approaches in COVID-19 Pneumonia: A Comparative Evaluation between a Specialized Center and Conventional Hospitals

    Healthcare (Switzerland), Vol. 12, Núm. 14

2023

  1. Relevance of subclinical right ventricular dysfunction measured by feature-tracking cardiac magnetic resonance in non-ischemic dilated cardiomyopathy

    BMC Cardiovascular Disorders, Vol. 23, Núm. 1

2022

  1. Early predictive risk factors for dimethyl fumarate-associated lymphopenia in patients with multiple sclerosis

    Multiple Sclerosis and Related Disorders, Vol. 59

2021

  1. Measuring Choroid Thickness as a Marker of Systemic Inflammation in Patients with Ankylosing Spondylitis

    Journal of Clinical Rheumatology, Vol. 27, Núm. 8, pp. E307-E311

2020

  1. AB0726 Choroidal Thickness Is a Biomarker a and Can Predict The Response to Treatment in Ankylosing Spondylitis

    Annals of the Rheumatic Diseases, Vol. 79, Núm. Suppl 1, pp. 1657.1-1658

  2. Adaptation and validation of the ICU Mobility Scale in Spain

    Enfermeria Intensiva, Vol. 31, Núm. 3, pp. 131-146

  3. Choroidal Thickness Is a Biomarker Associated With Response to Treatment in Ankylosing Spondylitis

    JCR: Journal of Clinical Rheumatology

  4. Three-Year Effectiveness of Dimethyl Fumarate in Multiple Sclerosis: A Prospective Multicenter Real-World Study

    CNS Drugs, Vol. 34, Núm. 12, pp. 1275-1286

  5. Tolerability and safety of dimethyl fumarate in relapsing multiple sclerosis: a prospective observational multicenter study in a real-life Spanish population

    Journal of Neurology, Vol. 267, Núm. 8, pp. 2362-2371

2019

  1. Conditions associated with REM sleep behaviour disorder: Description of a hospital series

    Neurologia, Vol. 34, Núm. 3, pp. 159-164

  2. Prognostic factors in neoadjuvant treatment followed by surgery in stage IIIA-N2 non-small cell lung cancer: a multi-institutional study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)

    Clinical and Translational Oncology, Vol. 21, Núm. 6, pp. 735-744

2018

  1. Neoadjuvant treatment followed by surgery versus definitive chemoradiation in stage IIIA-N2 non-small-cell lung cancer: A multi-institutional study by the oncologic group for the study of lung cancer (Spanish Radiation Oncology Society)

    Lung Cancer, Vol. 118, pp. 119-127